TCM Draft For Health Care Reform Unveiled
This article was originally published in PharmAsia News
China State Administration of Traditional Chinese Medicine has completed the basic draft of "Opinion on supporting and promoting TCM development." The document, as one of the components in China's heath care reform, specifies TCM's important role ranging from guiding principles to implementing concepts. In particular, it addresses issues on rural TCM work, compensation mechanisms and TCM practicing laws. In addition, the Ministry of Health has asked TCM administrative departments to accord as much emphasis on TCM as Western medicine by promoting TCM reform, accelerating legislation and strengthening talent cultivation. (Click here for more - Chinese Language)
You may also be interested in...
Advanced Imaging Group Calls For Swifter FDA Approvals For Mobile X-Ray, CT, Ultrasound Devices For COVID-19 Crisis
The Medical Imaging & Technology Alliance (MITA) recently sent a letter to the US FDA recommending steps the agency can take to help the advanced imaging industry quickly respond to the COVID-19 outbreak.
The two-year results from the PARTNER 3 trial showed transcatheter aortic valve replacement with Edwards Lifesciences' Sapien 3 system was statistically non-inferior to surgical valve replacement in low-risk patients. The one-year results from the trial had shown TAVR was superior to surgery in low-risk patients.
Experience and data from the study, which will use the same vector platform to deliver different transgenes for different diseases, could feed into the US FDA’s efforts to establish a public-private partnership to enable manufacturing of gene therapies for ultra-rare diseases.